TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 3 | 1 | 4 | 2 | 4 | 9 | 12 | -2 | -26 | -0 |
| S | %wins | 50 | 25 | 25 | 50 | 50 | 100 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/17/17 17:29 | 3/16/17 | VSAR | Versartis, Inc. | Health | Drug | Pharmaceutical Preparations | Malik Shahzad | X0 | D | S.m | -8,759 | 18.11 | 8 | -484 | -23 | 1,631 | I | -7 | 181 | 41 | 42 | 36 | -17 | -8 | -5 | 8 | 8 | 7 | |||||
3/15/17 17:44 | 3/13/17 | VSAR | Versartis, Inc. | Health | Drug | Pharmaceutical Preparations | Malik Shahzad | X0 | D | S.m | -3,175 | 19.09 | 8 | -166 | -7 | 2,114 | I | -4 | 175 | 40 | 45 | 33 | -3 | -11 | -5 | -3 | 4 | 8 | |||||
4/30/15 20:59 | 4/28/15 | AGEN | Agenus Inc | DE | Health | BioPrd | Biological Products, (No Diag | Malik Shahzad | MA | D | S.m | -7,871 | 7.11 | 12 | -1,107 | -100 | 0 | I | 43 | 140 | 132 | 39 | 33 | 33 | 23 | -1 | 4 | 0 | 22 | 23 | -26 | -39 | |
8/1/13 19:14 | 7/30/13 | CNAT | Conatus Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Malik Shahzad | CA | DT | S.d | -6 | 11.00 | 7 | -1 | 0 | 4,055 | I | -5 | -2 | 3 | 0 | 0 | 22 | -13 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |